Stockscreener 앱 받기
0.00
100.00%
-4.36
시간 외 거래:
4.60
4.60
+
전일 마감가:
$4.36
열려 있는:
$0
하루 거래량:
0
Relative Volume:
0.00
시가총액:
$96.26M
수익:
-
순이익/손실:
$-94.11M
주가수익비율:
0.00
EPS:
-6.01
순현금흐름:
$-86.06M
1주 성능:
-100.00%
1개월 성능:
-100.00%
6개월 성능:
-100.00%
1년 성능:
-100.00%
1일 변동 폭
$0.00
$0.00
1주일 범위
$0.00
$4.3785
52주 변동 폭
$0.00
$5.75
Adverum Biotechnologies Inc Stock (ADVM) Company Profile
명칭
Adverum Biotechnologies Inc
전화
(650) 649-1004
주소
100 CARDINAL WAY, REDWOOD CITY, CA
ADVM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ADVM
Adverum Biotechnologies Inc
|
0.00 | 96.26M | 0 | -94.11M | -86.06M | -6.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Adverum Biotechnologies Inc Stock (ADVM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-17 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2024-06-25 | 개시 | Oppenheimer | Outperform |
| 2024-04-30 | 개시 | H.C. Wainwright | Buy |
| 2022-07-07 | 업그레이드 | Truist | Hold → Buy |
| 2021-07-23 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2021-05-03 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2021-04-29 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2021-04-29 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-04-29 | 다운그레이드 | Truist | Buy → Hold |
| 2020-12-16 | 개시 | UBS | Neutral |
| 2020-11-12 | 업그레이드 | Raymond James | Underperform → Mkt Perform |
| 2020-06-26 | 다운그레이드 | Raymond James | Mkt Perform → Underperform |
| 2020-05-13 | 개시 | RBC Capital Mkts | Outperform |
| 2020-05-05 | 업그레이드 | SunTrust | Hold → Buy |
| 2020-04-28 | 개시 | Goldman | Buy |
| 2020-03-16 | 개시 | SVB Leerink | Outperform |
| 2020-02-10 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2020-02-10 | 업그레이드 | Chardan Capital Markets | Neutral → Buy |
| 2019-10-15 | 재확인 | Chardan Capital Markets | Neutral |
| 2019-09-13 | 재확인 | Chardan Capital Markets | Neutral |
| 2019-06-14 | 재개 | Raymond James | Mkt Perform |
| 2018-11-02 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2018-11-02 | 다운그레이드 | SunTrust | Buy → Hold |
| 2018-09-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-08-30 | 개시 | SunTrust | Buy |
| 2018-02-15 | 재개 | Piper Jaffray | Overweight |
| 2017-10-12 | 개시 | Raymond James | Outperform |
모두보기
Adverum Biotechnologies Inc 주식(ADVM)의 최신 뉴스
Hedge Fund and Insider Trading News: Cathie Wood, Michael Burry, Renaissance Technologies, Mason Capital, Millennium Management, Adverum Biotechnologies Inc (ADVM), MGM Resorts International (MGM), and More - Insider Monkey
Adverum Biotechnologies, Inc.(NasdaqCM: ADVM) dropped from S&P TMI Index - marketscreener.com
Lilly and Adverum announce expiration and completion of Adverum tender offer and acquisition - The Malaysian Reserve
Eli Lilly (LLY) Completes Acquisition of Adverum Biotechnologies - GuruFocus
Eli Lilly Moves Forward With Acquisition Of Adverum Biotechnologies - Nasdaq
Lilly completes tender offer for Adverum Biotechnologies - Investing.com
Monday’s Insider Moves: Adverum Execs Lead Buys, Diamondback Sale Tops - Investing.com Australia
Adverum Biotechnologies Stock (ADVM) Opinions on Lilly Acquisition - Quiver Quantitative
Lilly completes tender offer for Adverum Biotechnologies By Investing.com - Investing.com UK
Lilly completes Adverum acquisition for $3.56 per share plus CVRs - StreetInsider
Laurent Fischer Acquires 117,614 Shares of Adverum Biotechnologies (NASDAQ:ADVM) Stock - MarketBeat
Insider Buying: Laurent Fischer Acquires Shares of Adverum Biote - GuruFocus
Soparkar Peter, Adverum Biotechnologies COO, buys $211k in shares By Investing.com - Investing.com Canada
Adverum biotechnologies CEO Fischer buys shares worth $553916 By Investing.com - Investing.com Canada
Adverum Biotechnologies (NASDAQ:ADVM) Major Shareholder Sells $2,197,906.40 in Stock - Defense World
Insider Selling: Adverum Biotechnologies (NASDAQ:ADVM) Major Shareholder Sells $2,197,906.40 in Stock - MarketBeat
What analysts say about Adverum Biotechnologies Inc stockEarnings Per Share Trends & Try Our Free Strategy Builder Now - earlytimes.in
Owner Leonard Sells 524,560 ($2.2M) Of Adverum Biotechnologies Inc [ADVM] - TradingView
Adverum Reminds Stockholders to Tender Their Shares Into the Offer by Lilly - 富途牛牛
LUNA Surges 20% in a Day Amid Ongoing Terra Network Upgrade - Bitget
Why retail traders accumulate Adverum Biotechnologies Inc. (AVU0) stockWeekly Profit Report & Advanced Swing Trade Entry Alerts - Newser
Insider Selling: Adverum Biotechnologies (NASDAQ:ADVM) Major Shareholder Sells 222,925 Shares of Stock - MarketBeat
Adverum Biotechnologies (NASDAQ:ADVM) Major Shareholder Braden Michael Leonard Sells 51,961 Shares - MarketBeat
Adverum Biotechnologies Releases Promising Phase 2 Trial Data - TipRanks
Adverum Biotechnologies, Inc. Announces Two-Year Data from LUNA Phase 2 Trial - TradingView
How Adverum Biotechnologies Inc. (AVU0) stock reacts to stronger dollarJuly 2025 Highlights & Growth Oriented Trade Recommendations - Newser
Why Adverum Biotechnologies Inc. (AVU0) stock trades below fair valueMarket Performance Summary & Reliable Volume Spike Trade Alerts - Newser
Is Adverum Biotechnologies Inc. (AVU0) stock resilient in recession scenariosQuarterly Earnings Report & Entry and Exit Point Strategies - Newser
Adverum Biotechnologies releases promising phase 2 trial data - MSN
Leonard of Adverum Bio sells $2.4m in shares By Investing.com - Investing.com Canada
Owner Leonard Sells 574,886 ($2.4M) Of Adverum Biotechnologies Inc [ADVM] - TradingView
Is Adverum Biotechnologies Inc. (AVU0) stock undervalued by metricsJuly 2025 Catalysts & Safe Capital Investment Plans - Newser
Published on: 2025-12-02 05:06:35 - Newser
What technical patterns form on Adverum Biotechnologies Inc. (AVU0) stock charts - Newser
Will Adverum Biotechnologies Inc. (AVU0) stock return to pre crash levelsMarket Growth Review & Consistent Profit Trading Strategies - Newser
How Adverum Biotechnologies Inc. (AVU0) stock performs in volatility spikesQuarterly Market Review & Precise Trade Entry Recommendations - Newser
Eli Lilly’s tender offer for Adverum nears deadline amid liquidity concerns - Investing.com Canada
Adverum reminds stockholders to tender their shares into the offer by Lilly - marketscreener.com
Eli Lilly (LLY) Sets Tender Offer to Acquire Adverum Biotechnolo - GuruFocus
Eli Lilly’s tender offer for Adverum nears deadline amid liquidity concerns By Investing.com - Investing.com South Africa
Adverum Reminds Stockholders to Tender their Shares into the Offer by Lilly - The Manila Times
Bronstein, Gewirtz & Grossman, LLC Is Investigating Adverum Biote - The National Law Review
Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Adverum Biotechnologies Faces Lease Termination Notice - TipRanks
Adverum Biotechnologies IncARE-NC Region No. 21 LLC terminates certain lease agreement with Adverum BiotechnologiesSEC filing - MarketScreener
[8-K] Adverum Biotechnologies, Inc. Reports Material Event | ADVM SEC FilingForm 8-K - Stock Titan
Lilly strengthens gene therapy portfolio with MeiraGTx and Adverum deals - Drug Discovery News
Chart overlay techniques for tracking Adverum Biotechnologies Inc.2025 Price Targets & Low Risk Growth Stock Ideas - newser.com
Is Adverum Biotechnologies Inc. stock cheap compared to fundamentals2025 Retail Activity & Weekly High Momentum Picks - newser.com
Why Adverum Biotechnologies Inc. stock remains on watchlistsJuly 2025 Levels & Weekly High Conviction Ideas - newser.com
Adverum Biotechnologies (ADVM) Price Target Decreased by 11.61% to 10.10 - MSN
Adverum Biotechnologies Inc (ADVM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.08%
0.91%
자본화:
|
볼륨(24시간):